BigHat Biosciences is a biotechnology company that develops protein therapeutics using machine learning. The company's platform enables the rapid design and optimization of protein therapeutics, and is used to develop treatments for a variety of diseases, including cancer and autoimmune disorders. BigHat's technology is designed to be scalable, efficient, and cost-effective, and is used by pharmaceutical companies and academic researchers.